Publications by authors named "Michael Verneris"

Claim this Profile
L
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel.
Lauren E Appell, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly Pacenta, Michael R Verneris

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML.
Swati Naik, Richard Aplenc, Susanne H C Baumeister, Marco Becilli, Anand S Bhagwat, Michael R Verneris

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group.
Taymour Hammoudi, Silvia Nucera, Alexandre G Troullioud Lucas, Marc Ansari, Adriana Balduzzi, Michael R Verneris

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence.
Dejene M Tufa, Eric Hoffmeyer, Kristin L Schaller, Ben Kooiman, Elena Woods, Michael R Verneris

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study.
Zahra Hudda, Aaron Webster, Eric Anderson, Priscila Badia, Rochelle Bagatell, Michael R Verneris

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.
Swati Naik, Subodh Selukar, Aimee C Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Michael R Verneris

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental Group.
Candelaria Deimundo Roura, Persis Amrolia, Marc Ansari, Peter Bader, Adriana Balduzzi, Michael R Verneris

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells shape naive CD8+ T cell programming.
Cameron Manes, Miguel Guerrero Moreno, Jennifer Cimons, Marc A D'Antonio, Tonya M Brunetti, Michael R Verneris

J Clin Invest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell RNA Sequencing of Ewing Sarcoma Tumors Demonstrates Transcriptional Heterogeneity and Clonal Evolution.
Andrew Goodspeed, Avery Bodlak, Alexis B Duffy, Sarah Nelson-Taylor, Naoki Oike, Michael R Verneris

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The health risk of social disadvantage is transplantable into a new host.
Lucie M Turcotte, Tao Wang, Kirsten M Beyer, Steven W Cole, Stephen R Spellman, Michael R Verneris

Proc Natl Acad Sci U S A· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directing B7-H3 chimeric antigen receptor T cell homing through IL-8 induces potent antitumor activity against pediatric sarcoma.
Jessica A Lake, Elena Woods, Eric Hoffmeyer, Kristin L Schaller, Joselyn Cruz-Cruz, Michael R Verneris

J Immunother Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.
Andrew Goodspeed, Avery Bodlak, Alexis B Duffy, Sarah Nelson-Taylor, Naoki Oike, Michael Verneris

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant.
Ryotaro Nakamura, Corinna La Rosa, Dongyun Yang, Joshua A Hill, Armin Rashidi, Michael R Verneris

Haematologica· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy.
Cheri Adams, Michael Keller, Jennifer G Michlitsch, Paibel Aguayo-Hiraldo, Karin Chen, Michael R Verneris

Transplant Cell Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak, Michael R Verneris

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
Jennifer W Cao, Jessica Lake, Renata Impastato, Lyndah Chow, Luisanny Perez, Michael R Verneris

Cancer Immunol Immunother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
Kevin O McNerney, Amy Moskop, Lena E Winestone, Christina Baggott, Julie-An Talano, Michael R Verneris

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Michael R Verneris

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, Michael Verneris

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?
Laura McLaughlin, Edwin DeZoeten, Michael R Verneris

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to transplantation and pediatric acute myeloid leukemia outcomes.
Lindsey A Murphy, Kristen Miller, Amanda C Winters, Anna R K Franklin, Michael R Verneris

Bone Marrow Transplant· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment.
Joselyn Cruz Cruz, Kristen C Allison, Lauren S Page, Alexis J Jenkins, Xiaodong Wang, Michael R Verneris

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
Heather E Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R Verneris

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
Liora M Schultz, Anne Eaton, Christina Baggott, Jenna Rossoff, Snehit Prabhu, Michael R Verneris

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Michael R Verneris

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis